Peninsula biotech moves from IPO to chopping half its workforce in little more than a year
After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...
These Seattle-area life science startups raised $595 million in 36 hours. Here's what's going on.
In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a ...
ncbiotech.org4d
Vast Therapeutics Lands $15M Series A, $300K from CF Foundation
Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507) of Japan and a $300,000 award from the Cystic Fibrosis Foundation.
ncbiotech.org4d
LabCorp’s Improved COVID-19 Test OK’d for Emergency Use
Durham’s Tavros Therapeutics sold to subsidiary of German giant Bayer AG Durham-based Tavros Therapeutics, a precision oncology company spun out of Duke University, has been acquired by a subsidiary ...